iVIEW Therapeutics
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- $25M
Investors
- 5
About iVIEW Therapeutics
Established in 2019 and based in Zhuhai, China, iVIEW Therapeutics is a pharmaceutical company that focuses on research and development of ophthalmology, rhinology and dermatology drugs. The company is headquartered in Zhuhai, with a biotech center in Pennsylvania. As of 2022, the company has completed 7 international patents, 15 domestic patents, and 9 publications. The company CSO Dr. Zhu Qi is a postdoctoral fellow at Harvard Medical School and serves as general manager in BMS MI. The company's main business is research and development of ophthalmic, rhinological and dermatological drugs. The company has 3 self-developed technology platforms, including in-situ gel technology platform, nanomicellar technology platforms, and liposome technology platforms. The company's self-developed products include IVIEW-1201, IVIEW-1503, IVIEW-1001, IVIEW-1801, IVIEW-1501, IVIEW-1601, IVIEW-1701 and IVIEW-3601. The IVIEW-1201 for the treatment of acute conjunctivitis and the IVIEW-1503 for the treatment and protection of COVID-19. iVIEW Therapeutics, Inc. generates revenue by providing innovative topical drugs for ophthalmic, nasal, and dermatological treatments to the pharmaceutical market. In addition, it expects to submit a clinical phase III application for the treatment of adenoviral conjunctivitis at the FDA in 2025.
Who invested in iVIEW Therapeutics
5 investors across 2 rounds
See all investors in iVIEW Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about iVIEW Therapeutics
Who invested in iVIEW Therapeutics?
iVIEW Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iVIEW Therapeutics raised?
iVIEW Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did iVIEW Therapeutics last raise money?
iVIEW Therapeutics's most recent round on record is a Series A, in Jan 2025.
What does iVIEW Therapeutics do?
Established in 2019 and based in Zhuhai, China, iVIEW Therapeutics is a pharmaceutical company that focuses on research and development of ophthalmology, rhinology and dermatology drugs.
Where is iVIEW Therapeutics headquartered?
iVIEW Therapeutics is headquartered in Zhuhai, China.
Which VCs invest in companies like iVIEW Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at iVIEW Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like iVIEW Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.